BE2015C005I2 - - Google Patents
Download PDFInfo
- Publication number
- BE2015C005I2 BE2015C005I2 BE2015C005C BE2015C005C BE2015C005I2 BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2 BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2
- Authority
- BE
- Belgium
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/388,173 US7270800B2 (en) | 2000-08-24 | 2003-03-14 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
US10/645,847 US20050043523A1 (en) | 2003-08-22 | 2003-08-22 | Benzothiazole derivative compounds, compositions and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
BE2015C005I2 true BE2015C005I2 (en) | 2023-03-07 |
Family
ID=35057877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2015C005C BE2015C005I2 (en) | 2003-03-14 | 2015-01-27 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1611115B1 (en) |
JP (1) | JP4875487B2 (en) |
CN (2) | CN102532055B (en) |
AU (2) | AU2004221897B2 (en) |
BE (1) | BE2015C005I2 (en) |
BR (1) | BRPI0408274B8 (en) |
CY (2) | CY1113334T1 (en) |
DK (1) | DK1611115T3 (en) |
ES (1) | ES2393921T3 (en) |
HK (1) | HK1086270A1 (en) |
HU (1) | HUS1500006I1 (en) |
NO (3) | NO330861B1 (en) |
PL (1) | PL1611115T3 (en) |
PT (1) | PT1611115E (en) |
RU (1) | RU2440995C2 (en) |
SI (1) | SI1611115T1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7270800B2 (en) | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
HU230375B1 (en) | 2000-08-24 | 2016-03-29 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thioflavin derivatives and their use in diagnosis and treatment of alzheimer's disease |
WO2005112913A1 (en) * | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
GB0516564D0 (en) * | 2005-08-12 | 2005-09-21 | Ge Healthcare Ltd | Fluorination process |
KR101503940B1 (en) * | 2007-01-30 | 2015-03-18 | 지이 헬쓰케어 리미티드 | Tools for aiding in the diagnosis of neurodegenerative diseases |
CN101293878B (en) * | 2007-04-25 | 2010-12-15 | 中国科学院上海应用物理研究所 | Benzothiazole amino benzenes compounds, preparation method and application thereof |
KR20110046503A (en) * | 2008-07-24 | 2011-05-04 | 지멘스 메디컬 솔루션즈 유에스에이, 인크. | Useful imaging agents to identify AD etiology |
DK2338059T3 (en) * | 2008-09-23 | 2015-06-15 | Wista Lab Ltd | Ligands for aggregated tau molecules |
KR101770532B1 (en) | 2013-09-26 | 2017-08-22 | 에프. 호프만-라 로슈 아게 | Imidazo[1,2-a]pyridin-7-amines as imaging tools |
JP6260967B2 (en) * | 2013-11-06 | 2018-01-17 | 国立大学法人京都大学 | Radioactive iodine labeled compound and radiopharmaceutical containing the same |
CN103613589B (en) * | 2013-11-29 | 2016-03-30 | 江苏华益科技有限公司 | A kind of for the Novel PET imaging agent precursor in nerve degenerative diseases field and the synthetic method of standard substance |
ES2818107T3 (en) * | 2014-08-29 | 2021-04-09 | Chdi Foundation Inc | Huntingtin Protein Imaging Probes |
CN109400615B (en) * | 2017-08-18 | 2021-07-16 | 上海交通大学医学院附属新华医院 | Beta-amyloid targeted coumarin compound and preparation and application thereof |
GR1009516B (en) * | 2018-03-22 | 2019-05-02 | Εκεφε Δημοκριτος | Tricarbonyl complexes of transition metals with benzo-heterocyclic derivatives of the cyclopentadienyl anion with high penetration of the blood-brain barrier for application in diagnosis and therapy of diseases of the cns |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0001383A3 (en) * | 1996-11-22 | 2001-11-28 | Lilly Co Eli | N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use |
GB9919673D0 (en) * | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
HU230375B1 (en) * | 2000-08-24 | 2016-03-29 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thioflavin derivatives and their use in diagnosis and treatment of alzheimer's disease |
WO2002051821A1 (en) * | 2000-12-22 | 2002-07-04 | Astrazeneca Ab | Therapeutic compounds |
CN100422180C (en) * | 2001-04-23 | 2008-10-01 | 宾夕法尼亚州大学理事会 | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
GB0229686D0 (en) * | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
-
2004
- 2004-03-15 AU AU2004221897A patent/AU2004221897B2/en not_active Expired
- 2004-03-15 RU RU2005131872/04A patent/RU2440995C2/en not_active Application Discontinuation
- 2004-03-15 JP JP2006507179A patent/JP4875487B2/en not_active Expired - Lifetime
- 2004-03-15 SI SI200431952T patent/SI1611115T1/en unknown
- 2004-03-15 PL PL04720788T patent/PL1611115T3/en unknown
- 2004-03-15 ES ES04720788T patent/ES2393921T3/en not_active Expired - Lifetime
- 2004-03-15 BR BRPI0408274A patent/BRPI0408274B8/en active IP Right Grant
- 2004-03-15 DK DK04720788.1T patent/DK1611115T3/en active
- 2004-03-15 PT PT47207881T patent/PT1611115E/en unknown
- 2004-03-15 CN CN201110437182.5A patent/CN102532055B/en not_active Expired - Lifetime
- 2004-03-15 EP EP04720788A patent/EP1611115B1/en not_active Expired - Lifetime
- 2004-03-15 CN CNA2004800125035A patent/CN1784392A/en active Pending
-
2005
- 2005-10-11 NO NO20054674A patent/NO330861B1/en active Protection Beyond IP Right Term
-
2006
- 2006-07-04 HK HK06107502.0A patent/HK1086270A1/en not_active IP Right Cessation
-
2011
- 2011-02-16 AU AU2011200667A patent/AU2011200667B2/en not_active Expired
- 2011-07-06 NO NO20110980A patent/NO20110980L/en not_active Application Discontinuation
-
2012
- 2012-11-16 CY CY20121101106T patent/CY1113334T1/en unknown
-
2015
- 2015-01-27 BE BE2015C005C patent/BE2015C005I2/fr unknown
- 2015-02-18 NO NO2015005C patent/NO2015005I1/en not_active IP Right Cessation
- 2015-02-18 HU HUS1500006C patent/HUS1500006I1/en unknown
- 2015-03-04 CY CY2015007C patent/CY2015007I1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102532055B (en) | 2016-05-11 |
HUS1500006I1 (en) | 2015-02-18 |
NO2015005I1 (en) | 2015-03-02 |
JP4875487B2 (en) | 2012-02-15 |
RU2440995C2 (en) | 2012-01-27 |
BRPI0408274A (en) | 2006-03-21 |
RU2005131872A (en) | 2006-02-27 |
CN1784392A (en) | 2006-06-07 |
CY2015007I1 (en) | 2015-12-09 |
AU2004221897A9 (en) | 2009-08-20 |
AU2011200667A1 (en) | 2011-03-10 |
PT1611115E (en) | 2012-12-07 |
NO330861B1 (en) | 2011-08-01 |
NO20110980L (en) | 2005-12-13 |
PL1611115T3 (en) | 2013-01-31 |
EP1611115B1 (en) | 2012-08-22 |
AU2004221897A2 (en) | 2004-09-30 |
CN102532055A (en) | 2012-07-04 |
AU2004221897B2 (en) | 2010-11-18 |
ES2393921T3 (en) | 2013-01-02 |
EP1611115A1 (en) | 2006-01-04 |
DK1611115T3 (en) | 2012-11-26 |
SI1611115T1 (en) | 2012-12-31 |
JP2006522104A (en) | 2006-09-28 |
AU2004221897A1 (en) | 2004-09-30 |
AU2011200667B2 (en) | 2011-12-22 |
NO20054674L (en) | 2005-12-13 |
NO2015005I2 (en) | 2015-02-18 |
BRPI0408274B8 (en) | 2021-05-25 |
CY1113334T1 (en) | 2015-12-09 |
HK1086270A1 (en) | 2006-09-15 |
BRPI0408274B1 (en) | 2019-02-26 |
NO20054674D0 (en) | 2005-10-11 |